HealthStream Inc. Reports Q2 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

Reuters
Aug 12
HealthStream Inc. Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

HealthStream Inc. has reported its financial results for the second quarter of 2025, revealing revenues of $674.4 million. This represents an increase from the fiscal year 2024 revenues, which stood at $6291.6 million. Additionally, the company's quarterly adjusted EBITDA reached $517.6 million, compared to the fiscal year 2024 adjusted EBITDA of $566.8 million. HealthStream boasts a strong balance sheet with $690.6 million in cash as of the second quarter of 2025 and no debt. The company continues to serve the U.S. healthcare industry with enterprise-level, subscription-based products, generating recurring revenues. HealthStream remains a market leader in workforce solutions for learning, credentialing, and scheduling within healthcare organizations. The company is focused on addressing the industry's challenges in improving patient safety and workforce retention.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthStream Inc. published the original content used to generate this news brief on August 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10